Your browser doesn't support javascript.
loading
[Progress of genomic mutation spectrum in biliary tract malignant tumors].
Qiu, S M; Liu, F T; Wu, W W; Liu, Y B.
Afiliação
  • Qiu SM; School of Health Science and Engineering,University of Shanghai for Science and Technology,Shanghai 200093,China.
  • Liu FT; Shanghai Cancer Institute,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200032,China.
  • Wu WW; Department of Biliary-Pancreatic Surgery,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China.
  • Liu YB; Department of Biliary-Pancreatic Surgery,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China.
Zhonghua Wai Ke Za Zhi ; 61(12): 1124-1129, 2023 Dec 01.
Article em Zh | MEDLINE | ID: mdl-37932150
ABSTRACT
Biliary tract cancer is characterized by high invasiveness, occult early clinical manifestations and rapid progression. Surgical resection typically fails to achieve satisfactory outcomes. Biliary tract cancer exhibits low sensitivity to radiotherapy and chemotherapy. The prognosis of patients is extremely poor. Genomics research based on next-generation sequencing technology has made some advances. The gene mutation spectrum of biliary tract cancer has been preliminarily revealed, which lays a foundation for the study of molecular typing. This review summarizes the research progress and clinical application of gene mutation spectrum of biliary tract cancer in recent years, aiming to provide reference for the clinical diagnosis, treatment and basic research.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Biliar / Neoplasias do Sistema Biliar Limite: Humans Idioma: Zh Revista: Zhonghua Wai Ke Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Biliar / Neoplasias do Sistema Biliar Limite: Humans Idioma: Zh Revista: Zhonghua Wai Ke Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China